Teva to buy Auspex for $101/share in cash
Drugmaker Teva (Tel Aviv Stock Exchange: TEVA-IL)Pharmaceuticals said it would buy Auspex (NASDAQ: ASPX)for $101 per share in cash, or $3.5 billion in equity value.
Teva said the deal would add a portfolio of drugs for the treatment of central nervous system disorders.
Auspex shares closed Friday at $70.91.
More From CNBC